UBS Group AG - REALM THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

REALM THERAPEUTICS PLC's ticker is RLM and the CUSIP is 75606L103. A total of 4 filers reported holding REALM THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of REALM THERAPEUTICS PLC
ValueSharesWeighting
Q2 2019$7,000
+600.0%
2,558
+1361.7%
0.00%–
Q1 2019$1,0000.0%175
-68.1%
0.00%–
Q4 2018$1,000
-83.3%
549
-70.5%
0.00%–
Q3 2018$6,000–1,860–0.00%–
 Download
Other shareholders
REALM THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 360,866$1,173,0000.10%
Orbimed Advisors 1,021,484$3,051,0000.04%
UBS Group AG 1,860$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REALM THERAPEUTICS PLC shareholders